Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Microb Pathog. 2018 Oct;123:28-35. doi: 10.1016/j.micpath.2018.06.024. Epub 2018 Jun 26.
The Lactococcus lactis is known as a probiotic bacterium and also as a producer of nisin. Nisin has been approved by related legal agencies to be used as an antimicrobial peptide in food preservation. In fact, the L. lactis is present in different food products along with other micro-organisms especially pathogenic bacteria. So, it is important to predict the behavior of nisin-producer strain in contact with other pathogens. In this regard, nisin gene expression and the level of secreted biologically active form of nisin by L. lactis subsp. lactis in modified MRS broth and whey solution in co-culture with Listeria monocytogenes or Salmonella enterica were studied. The nisin concentration was determined by microbiological assay method and the transcription level of nisin gene was assayed through quantitative reverse transcription PCR (RT-qPCR). According to our results, the highest concentration of nisin and its gene transcription level were detected in mono- and co-cultures after 16 h of incubation, concurrent with the end of L. lactis exponential phase of growth. The nisin mRNA copies in co-cultures were higher than mono-cultures only at 16 h of incubation. But, differences between nisin concentrations in mono- and co-cultures were significant at 16, 24 h and at 12, 16, 24 h of incubation in the modified MRS medium and whey solution, respectively. This incompatibility could be related to the low availability of components required for nisin precursor modification, transportation and processing in mono-cultures. Overall, the L. lactis produced more mature and active nisin when it was in contact with pathogenic bacteria.
乳球菌被认为是一种益生菌,也是乳链菌肽的生产者。乳链菌肽已被相关法律机构批准作为食品防腐剂中的一种抗菌肽。事实上,乳球菌与其他微生物(尤其是病原菌)一起存在于不同的食品中。因此,预测产乳链菌肽菌株与其他病原体接触时的行为非常重要。在这方面,研究了乳球菌亚种在改良 MRS 肉汤和乳清溶液中与单核细胞增生李斯特菌或肠炎沙门氏菌共培养时,乳链菌肽基因表达和分泌具有生物活性形式的乳链菌肽的水平。通过微生物测定法确定乳链菌肽的浓度,通过定量逆转录 PCR(RT-qPCR)测定乳链菌肽基因的转录水平。根据我们的结果,在 16 小时的孵育后,无论是在单培养物还是共培养物中,都检测到了最高浓度的乳链菌肽及其基因转录水平,这与乳球菌生长指数期的结束时间相一致。在共培养物中,乳链菌肽 mRNA 拷贝数仅在 16 小时的孵育时高于单培养物。但是,在改良 MRS 培养基和乳清溶液中,分别在 16、24 小时和 12、16、24 小时的孵育时,单培养物和共培养物中的乳链菌肽浓度存在显著差异。这种不兼容性可能与单培养物中乳链菌肽前体修饰、运输和加工所需成分的低可用性有关。总的来说,当乳球菌与病原菌接触时,会产生更多成熟和有活性的乳链菌肽。